首页 > 市场调查报告书 > 医疗设备

体外诊断

疟疾诊断市场规模、份额和成长分析（按产品、技术、应用和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902503

疟疾诊断市场规模、份额和成长分析（按产品、技术、应用和地区划分）－2026-2033年产业预测

Malaria Diagnostics Market Size, Share, and Growth Analysis, By Product (Instruments, Kits & reagents), By Technology (Microscopy, Rapid diagnostic tests), By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球疟疾诊断市场规模将达到 8.842 亿美元，到 2025 年将达到 9.2576 亿美元，到 2033 年将达到 13.3682 亿美元，在预测期（2026-2033 年）内复合年增长率为 4.7%。

由于调查方法的技术进步，特别是分子诊断和快速诊断测试（RDT）领域的技术进步，全球疟疾诊断市场正经历显着扩张。这些创新提高了灵敏度、特异性和易用性，使得就地检验（POCT）越来越受欢迎，尤其是在资源匮乏的地区。人们对早期疟疾检测重要性的认识不断提高、政府的支持性政策以及全球卫生组织的资金投入，都进一步推动了市场成长。然而，偏远地区医疗基础设施的匮乏、成本效益问题以及对某些诊断测试可靠性的质疑等挑战可能会阻碍市场发展。克服这些障碍需要公共和私营部门利益相关人员的合作，共同开发可近、有效且符合当地文化的诊断解决方案，从而显着降低疟疾在全球的影响。

推动全球疟疾诊断市场发展的因素

全球疟疾诊断市场深受疟疾高发地区的影响，尤其是撒哈拉以南非洲和亚洲部分地区。在这些地区，准确快速的诊断解决方案对于成功控制和遏制疟疾至关重要。由于疟疾仍然是严重的公共卫生挑战，快速识别病例和製定高效治疗方案的需求推动了对创新诊断工具的需求。满足这些诊断需求对于改善健康状况和促进有效的疟疾控制至关重要。

全球疟疾诊断市场限制因素

全球疟疾诊断市场面临研发投入不足的挑战，可能限制创新诊断技术的出现。缺乏资金支持旨在开发更灵敏、更特异、更经济的诊断测试的研究倡议，阻碍了这一重要领域的发展。如果没有足够的资金支持，改善诊断工具的研发过程可能会受阻，从而影响疟疾检测和控制策略的整体有效性。因此，缺乏创新可能导致疟疾控制面临持续的挑战，并限制医疗卫生系统有效应对疟疾的能力。

全球疟疾诊断市场趋势

全球疟疾诊断市场正经历着向亚洲、拉丁美洲和非洲等新兴市场的重大转移。这一趋势主要受医疗保健投资增加和公众对感染疾病认识的提高所推动。这些地区的政府已实施强而有力的疟疾防治政策，为市场成长创造了有利条件。各公司正抓住这项机会，开发经济高效且符合当地文化的诊断解决方案，以满足当地居民的特定需求。这种策略重点不仅提高了诊断服务的可近性，还促进了与当地医疗机构的伙伴关係，为公司有效进入并立足这些快速成长的市场奠定了基础。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Abbott Laboratories（United States）
Bio-Rad Laboratories, Inc.（United States）
Siemens Healthineers AG（Germany）
Thermo Fisher Scientific Inc.（United States）
F. Hoffmann-La Roche Ltd（Switzerland）
bioMerieux SA（France）
Beckman Coulter, Inc.（United States）
Cepheid Inc.（United States）
Danaher Corporation（United States）
Hologic, Inc.（United States）
Illumina, Inc.（United States）
Qiagen NV（Netherlands）
Sysmex Corporation（Japan）
Nikon Corporation（Japan）
Olympus Corporation（Japan）
DiaSorin SpA（Italy）
Trinity Biotech plc（Ireland）
FujiFilm Corporation（Japan）

结论与建议

简介目录

Product Code: SQMIG35B2208

Global Malaria Diagnostics Market size was valued at USD 884.2 Million in 2024 and is poised to grow from USD 925.76 Million in 2025 to USD 1336.82 Million by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).

The global malaria diagnostics market is experiencing remarkable expansion driven by technological advancements in diagnostic methodologies, particularly in molecular diagnostics and rapid diagnostic tests (RDTs). These innovations enhance sensitivity and specificity and facilitate easier usage, making point-of-care testing increasingly popular, especially in resource-limited settings. The growing awareness of early malaria detection and supportive governmental initiatives, alongside funding from organizations dedicated to global health, further bolster market growth. However, challenges such as inadequate healthcare infrastructure in remote areas, affordability issues, and questions regarding the reliability of some diagnostic tests may impede progress. Overcoming these barriers necessitates collaborative efforts among public and private sector stakeholders to create accessible, effective, and culturally appropriate diagnostic solutions that can substantially mitigate malaria's impact worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Malaria Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Malaria Diagnostics Market Segments Analysis

Global Malaria Diagnostics Market is segmented by Product, Technology, End-use and region. Based on Product, the market is segmented into Instruments and Kits & reagents. Based on Technology, the market is segmented into Microscopy, Rapid diagnostic tests, Molecular diagnostic tests and Other technologies. Based on End-use, the market is segmented into Clinics, Hospitals, Diagnostic centers and Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market is significantly influenced by regions facing a substantial malaria burden, especially in sub-Saharan Africa and certain areas of Asia. In these locations, the imperative for precise and prompt diagnostic solutions becomes paramount for the successful management and containment of the disease. As malaria continues to pose a serious public health challenge, the demand for innovative diagnostic tools rises, driven by the necessity for rapid identification of cases and efficient treatment decisions. Addressing these diagnostic needs is essential for improving health outcomes and advancing efforts to combat malaria effectively.

Restraints in the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market faces challenges due to inadequate investment in research and development, which may restrict the emergence of innovative diagnostic technologies. This scarcity of funding for research initiatives aimed at creating more sensitive, specific, and cost-effective diagnostic tests impedes advancement in this vital area. Without sufficient financial support, progress in developing improved diagnostic tools is hindered, potentially affecting the overall effectiveness of malaria detection and management strategies. Consequently, the lack of innovation can lead to persistent challenges in addressing malaria effectively, limiting the ability of healthcare systems to combat the disease efficiently.

Market Trends of the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market is witnessing a significant shift towards emerging markets across Asia, Latin America, and Africa, driven by escalating healthcare investments and heightened public awareness of infectious diseases. Governments in these regions are implementing robust initiatives to combat malaria, creating a fertile landscape for growth. Companies are seizing this opportunity by developing cost-effective and culturally attuned diagnostic solutions that meet the specific needs of local populations. This strategic focus not only enhances accessibility to diagnostics but also fosters partnerships with local healthcare providers, thereby positioning businesses to effectively penetrate and establish a foothold in these burgeoning markets.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Malaria Diagnostics Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
Kits & reagents

Global Malaria Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Microscopy
Rapid diagnostic tests
Molecular diagnostic tests
- Conventional PCR
- Real-time PCR
Other technologies

Global Malaria Diagnostics Market Size by End-use & CAGR (2026-2033)

Market Overview
Clinics
Hospitals
Diagnostic centers
Other end-users

Global Malaria Diagnostics Market Size & CAGR (2026-2033)

North America (Product, Technology, End-use)
- US
- Canada
Europe (Product, Technology, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technology, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technology, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technology, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nikon Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FujiFilm Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments